Details for New Drug Application (NDA): 018066
✉ Email this page to a colleague
NDA 018066 describes UNISOM, which is a drug marketed by Pfizer and Chattem and is included in two NDAs. Additional details are available on the UNISOM profile page.
The generic ingredient in UNISOM is doxylamine succinate. There are fourteen drug master file entries for this compound. Thirty-one suppliers are listed for this compound. Additional details are available on the doxylamine succinate profile page.
The generic ingredient in UNISOM is doxylamine succinate. There are fourteen drug master file entries for this compound. Thirty-one suppliers are listed for this compound. Additional details are available on the doxylamine succinate profile page.
Summary for 018066
| Tradename: | UNISOM |
| Applicant: | Chattem |
| Ingredient: | doxylamine succinate |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 018066
Profile for product number 001
| Active Rx/OTC/Discontinued: | OTC | Dosage: | TABLET;ORAL | Strength | 25MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
